Content Block Tag: NRG-HN005: RT with Immuno for HPV+ Oropharyngeal Cancer

‘Text/HTML’ of page ‘NRG-HN005: RT with Immuno for HPV+ Oropharyngeal Cancer’

Am I eligible for this study? If you are over the age of 18 years with low-risk, Human Papillomavirus (HPV) positive oropharyngeal cancer, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take this information to your doctor […]

‘Text/HTML’ of page ‘NRG-HN005: RT with Immuno for HPV+ Oropharyngeal Cancer’

About This Study NRG-HN005 is a clinical study for people with Human Papillomavirus (HPV) positive oropharyngeal cancer. This study has two parts called “phase II” and “phase III”. Typically, people with your type of cancer are treated with radiation therapy and chemotherapy, also known as the “usual approach”. For patients who get the usual […]

‘Text/HTML’ of page ‘NRG-HN005: RT with Immuno for HPV+ Oropharyngeal Cancer’

Clinical Studies FAQ

‘Text/HTML’ of page ‘NRG-HN005: RT with Immuno for HPV+ Oropharyngeal Cancer’

The NRG-HN005 Study FAQ